CN Stock MarketDetailed Quotes

002007 Hualan Biological Engineering, Inc.

Watchlist
  • 17.82
  • +0.44+2.53%
Market Closed Dec 20 15:00 CST
32.59BMarket Cap24.34P/E (TTM)

Hualan Biological Engineering, Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
30.88%843.16M
90.31%2.03B
61.21%1.17B
-9.55%993.77M
-43.49%644.21M
-46.26%1.07B
-65.07%726.15M
58.64%1.1B
-29.86%1.14B
58.41%1.98B
Transactional financial assets
-30.53%1.78B
-31.28%1.63B
11.36%3.15B
-10.74%2.11B
3.51%2.56B
-18.52%2.37B
1.83%2.83B
-10.90%2.37B
-17.09%2.47B
8.84%2.9B
Notes receivable and accounts receivable
-9.71%2.37B
17.72%1.75B
1.45%2.1B
2.87%2.3B
-4.43%2.62B
-41.75%1.49B
14.18%2.07B
21.93%2.23B
28.08%2.74B
136.67%2.55B
-Accounts receivable
-9.71%2.37B
17.72%1.75B
1.45%2.1B
2.87%2.3B
-4.43%2.62B
-41.75%1.49B
14.18%2.07B
21.93%2.23B
28.08%2.74B
136.67%2.55B
Other receivables (including interest and dividends)
126.15%16.57M
82.51%16.58M
123.23%18.86M
41.63%6.6M
22.83%7.33M
59.92%9.09M
-31.76%8.45M
8.58%4.66M
-66.31%5.96M
-49.95%5.68M
-Other receivable
----
82.51%16.58M
----
----
----
59.92%9.09M
----
8.58%4.66M
----
-39.37%5.68M
Advance payment
63.83%68.1M
114.84%71.66M
67.67%58.85M
13.73%33.53M
2.48%41.57M
-47.47%33.35M
-69.13%35.1M
-19.61%29.48M
-36.19%40.56M
12.09%63.49M
Inventories
11.82%1.91B
6.86%1.92B
17.31%1.92B
15.69%1.67B
8.21%1.7B
13.76%1.8B
-1.79%1.64B
6.47%1.45B
9.67%1.58B
5.07%1.58B
Receivable financing
9.73%145.78M
274.94%211.1M
110.91%143.69M
65.01%293.91M
-42.45%132.86M
-62.30%56.3M
-31.55%68.13M
-33.18%178.11M
22.09%230.86M
-24.56%149.33M
Assets held for sale
----
----
----
----
----
----
----
--132.08M
----
----
Non-current assets due within one year
130.59%2.05B
50.99%1.33B
177.27%1.14B
405.61%1.21B
--888.98M
--882.85M
--410M
--240M
----
----
Other current assets
7,608.97%90.09M
237.74%60.06M
56,973.79%151.81M
102.29%701.17M
665.41%1.17M
6,549.14%17.78M
-90.21%265.99K
12,454.88%346.61M
-94.68%152.69K
-90.93%267.47K
Total current assets
7.70%9.27B
16.86%9.02B
26.55%9.86B
15.47%9.33B
4.79%8.6B
-16.48%7.72B
-9.11%7.79B
17.90%8.08B
-2.96%8.21B
36.42%9.24B
Non Current assets
Long-term equity investment
-81.21%6.03M
-64.00%12.99M
-51.79%21.52M
-62.24%26.44M
-57.43%32.12M
-55.84%36.09M
-48.26%44.64M
-27.39%70.02M
-28.85%75.44M
-16.69%81.72M
Fixed assets
----
0.71%2.08B
----
----
----
-7.88%2.07B
----
-6.36%2.06B
----
55.78%2.24B
Constru in process
----
190.20%705.12M
----
----
----
92.60%242.98M
----
62.75%216.39M
----
-75.62%126.15M
Productive biological assets
-45.45%856.33K
----
54.95%367.15K
49.03%965.1K
16.26%1.57M
-45.48%349K
-60.08%236.94K
-58.70%647.59K
-46.79%1.35M
0.79%640.15K
Intangible assets
-0.41%315.93M
-0.95%318.96M
4.37%321.83M
3.13%319.72M
1.10%317.23M
1.81%322.01M
49.90%308.35M
51.57%310M
51.95%313.79M
64.05%316.28M
Development expenditure
7.23%27.64M
9.68%27.44M
10.87%26.92M
8.71%26.27M
7.59%25.77M
7.70%25.02M
5.55%24.28M
7.27%24.16M
7.97%23.95M
6.01%23.23M
Goodwill
----
----
0.00%1.1M
0.00%1.1M
0.00%1.1M
0.00%1.1M
0.00%1.1M
0.00%1.1M
0.00%1.1M
0.00%1.1M
Long deferred expense
22.97%30M
25.67%32.7M
120.78%34.6M
81.85%33.33M
1.57%24.4M
2.80%26.02M
-49.01%15.67M
-44.27%18.33M
-34.20%24.02M
-3.96%25.31M
Deferred tax assets
-11.51%207.86M
6.74%242.47M
0.87%228.28M
3.97%241.72M
8.07%234.89M
4.59%227.16M
8.90%226.31M
15.52%232.49M
17.01%217.34M
6.72%217.19M
Usufruct assets
-3.96%9.26M
-3.76%9.41M
-5.29%9.39M
-5.36%9.52M
24,011.61%9.64M
17,669.52%9.77M
14,059.76%9.91M
11,729.92%10.06M
--40K
--55K
Other non current assets
-10.40%3.41B
-16.49%3.19B
-31.53%3B
-8.50%3.4B
12.87%3.8B
63.00%3.82B
69.90%4.38B
107.83%3.72B
942.30%3.37B
802.33%2.34B
Total non current assets
-1.33%6.84B
-2.31%6.62B
-12.07%6.41B
1.70%6.78B
8.59%6.93B
26.00%6.78B
34.38%7.29B
42.24%6.67B
119.12%6.38B
94.76%5.38B
Total assets
3.67%16.1B
7.90%15.64B
7.87%16.27B
9.24%16.11B
6.45%15.53B
-0.85%14.49B
7.75%15.08B
27.79%14.74B
28.30%14.59B
53.32%14.62B
Liabilities
Current liabilities
Short term loan
0.00%600M
12.50%900M
0.00%800M
-12.50%700.35M
0.00%600M
-27.27%800M
0.00%800M
-0.04%800.38M
-45.45%600M
266.67%1.1B
Notes payable and accounts payable
-0.54%204.66M
0.48%210.36M
14.78%244.12M
12.41%197.26M
-48.37%205.77M
-10.02%209.35M
-36.81%212.68M
-27.19%175.49M
107.16%398.56M
23.02%232.65M
-Notes payable
120.68%6.91M
-35.10%12.01M
97.21%19.86M
----
-98.58%3.13M
101.66%18.51M
-81.50%10.07M
-36.61%15.31M
563.71%220.18M
-84.28%9.18M
-Accounts payable
-2.41%197.75M
3.94%198.34M
10.68%224.26M
23.15%197.26M
13.60%202.64M
-14.60%190.83M
-28.19%202.61M
-26.14%160.17M
12.04%178.38M
70.94%223.47M
Contract liabilities
-11.83%9.79M
101.94%19.2M
-10.36%10.14M
-42.01%8.57M
39.26%11.11M
-13.09%9.51M
139.87%11.31M
78.65%14.78M
87.23%7.98M
82.01%10.94M
Advance receipts
----
----
----
----
----
----
----
----
--12.6K
----
Salaries payable
-57.48%514.7K
-71.54%136.39K
20.45%492.93K
39.18%27.89K
180.63%1.21M
405.13%479.22K
25.89%409.25K
-99.52%20.04K
-90.63%431.38K
-97.80%94.87K
Taxs payable
-50.37%72.19M
-11.99%35.67M
-49.30%24.53M
145.07%87.75M
48.52%145.47M
-73.50%40.52M
-26.43%48.38M
-55.46%35.81M
-31.63%97.94M
126.50%152.92M
Other payable (including interest and dividends)
-0.08%1.25B
21.13%1.02B
5.72%1.08B
14.80%1.29B
4.88%1.25B
-31.00%840.11M
9.86%1.02B
4.77%1.12B
11.40%1.2B
45.50%1.22B
-Dividend payable
--93.32M
--93.32M
----
----
----
----
----
----
----
--6.75M
-Other payable
----
10.02%924.3M
----
----
----
-30.62%840.11M
----
5.17%1.12B
----
44.70%1.21B
Non current liabilities due within one year
24,357.32%150.76M
62,880.98%150.76M
127,194.94%300M
68,345.11%300.36M
-95.89%616.43K
-98.40%239.38K
-97.64%235.67K
-95.69%438.83K
--15M
--15M
Other current liabilities
-11.84%293.7K
102.01%575.87K
-10.37%304K
-41.97%257.11K
39.81%333.16K
-12.18%285.07K
139.90%339.16K
78.83%443.03K
86.55%238.3K
81.92%324.6K
Total current liabilities
3.28%2.29B
22.83%2.33B
17.40%2.46B
20.16%2.58B
-4.21%2.22B
-30.37%1.9B
-2.44%2.1B
-3.01%2.15B
-8.03%2.32B
94.42%2.73B
Current liabilities
Long term loan
----
----
----
----
66.67%300M
66.67%300M
57.89%300M
57.89%300M
--180M
--180M
Deferred tax liabilities
32.52%44.74M
35.73%40.82M
85.82%41.36M
105.15%42.82M
129.72%33.76M
123.76%30.07M
15.58%22.26M
101.28%20.87M
150.32%14.7M
-30.11%13.44M
Long term deferred income
-11.58%46.46M
-7.08%48.09M
-6.46%49.63M
-5.87%51.18M
-7.40%52.54M
-6.69%51.75M
-8.11%53.06M
-6.11%54.37M
8.38%56.74M
5.94%55.46M
Lease liabilities
-4.25%8.67M
-11.76%8.57M
-3.96%9.23M
-1.60%9.15M
--9.06M
--9.71M
--9.61M
--9.3M
----
----
Total non current liabilities
-74.74%99.87M
-75.11%97.47M
-73.96%100.22M
-73.18%103.15M
57.24%395.36M
57.30%391.53M
44.17%384.93M
48.89%384.54M
331.83%251.44M
247.70%248.9M
Total liabilities
-8.53%2.39B
6.10%2.43B
3.22%2.56B
5.99%2.68B
1.81%2.61B
-23.05%2.29B
2.71%2.48B
2.41%2.53B
-0.35%2.57B
101.86%2.98B
Shareholders equity
Paid-in capital
0.24%1.83B
0.24%1.83B
0.24%1.83B
0.24%1.83B
0.00%1.82B
0.00%1.82B
0.00%1.82B
0.00%1.82B
0.00%1.82B
0.00%1.82B
Capital reserve funds
1.19%1.45B
4.08%1.48B
5.34%1.5B
4.97%1.49B
1.40%1.43B
1.05%1.42B
0.70%1.42B
1,239.92%1.42B
1,246.75%1.41B
1,258.62%1.41B
Surplus reserve funds
9.31%806.81M
9.31%806.81M
9.31%806.81M
9.31%806.81M
8.82%738.08M
8.82%738.08M
8.82%738.08M
8.82%738.08M
19.35%678.23M
19.35%678.23M
Retained profit
10.38%7.66B
12.15%7.18B
11.45%7.55B
13.48%7.29B
10.08%6.94B
6.89%6.4B
12.82%6.77B
11.29%6.42B
11.85%6.31B
18.85%5.99B
Less:Treasury stock
--46.75M
--46.75M
--48.07M
--48.07M
----
----
----
----
----
----
Shareholders equity without minority interests
6.99%11.7B
8.30%11.25B
8.15%11.63B
9.24%11.36B
7.00%10.93B
4.92%10.39B
8.49%10.76B
24.73%10.4B
26.24%10.22B
32.12%9.9B
Minority interests
1.46%2.01B
7.87%1.96B
12.53%2.08B
13.78%2.06B
9.94%1.99B
4.32%1.81B
10.70%1.85B
149.22%1.81B
157.02%1.81B
207.93%1.74B
Total shareholder equity
6.14%13.71B
8.24%13.21B
8.79%13.71B
9.92%13.42B
7.44%12.92B
4.83%12.2B
8.81%12.6B
34.71%12.21B
36.68%12.02B
44.43%11.64B
Total liabilityies and equity
3.67%16.1B
7.90%15.64B
7.87%16.27B
9.24%16.11B
6.45%15.53B
-0.85%14.49B
7.75%15.08B
27.79%14.74B
28.30%14.59B
53.32%14.62B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 30.88%843.16M90.31%2.03B61.21%1.17B-9.55%993.77M-43.49%644.21M-46.26%1.07B-65.07%726.15M58.64%1.1B-29.86%1.14B58.41%1.98B
Transactional financial assets -30.53%1.78B-31.28%1.63B11.36%3.15B-10.74%2.11B3.51%2.56B-18.52%2.37B1.83%2.83B-10.90%2.37B-17.09%2.47B8.84%2.9B
Notes receivable and accounts receivable -9.71%2.37B17.72%1.75B1.45%2.1B2.87%2.3B-4.43%2.62B-41.75%1.49B14.18%2.07B21.93%2.23B28.08%2.74B136.67%2.55B
-Accounts receivable -9.71%2.37B17.72%1.75B1.45%2.1B2.87%2.3B-4.43%2.62B-41.75%1.49B14.18%2.07B21.93%2.23B28.08%2.74B136.67%2.55B
Other receivables (including interest and dividends) 126.15%16.57M82.51%16.58M123.23%18.86M41.63%6.6M22.83%7.33M59.92%9.09M-31.76%8.45M8.58%4.66M-66.31%5.96M-49.95%5.68M
-Other receivable ----82.51%16.58M------------59.92%9.09M----8.58%4.66M-----39.37%5.68M
Advance payment 63.83%68.1M114.84%71.66M67.67%58.85M13.73%33.53M2.48%41.57M-47.47%33.35M-69.13%35.1M-19.61%29.48M-36.19%40.56M12.09%63.49M
Inventories 11.82%1.91B6.86%1.92B17.31%1.92B15.69%1.67B8.21%1.7B13.76%1.8B-1.79%1.64B6.47%1.45B9.67%1.58B5.07%1.58B
Receivable financing 9.73%145.78M274.94%211.1M110.91%143.69M65.01%293.91M-42.45%132.86M-62.30%56.3M-31.55%68.13M-33.18%178.11M22.09%230.86M-24.56%149.33M
Assets held for sale ------------------------------132.08M--------
Non-current assets due within one year 130.59%2.05B50.99%1.33B177.27%1.14B405.61%1.21B--888.98M--882.85M--410M--240M--------
Other current assets 7,608.97%90.09M237.74%60.06M56,973.79%151.81M102.29%701.17M665.41%1.17M6,549.14%17.78M-90.21%265.99K12,454.88%346.61M-94.68%152.69K-90.93%267.47K
Total current assets 7.70%9.27B16.86%9.02B26.55%9.86B15.47%9.33B4.79%8.6B-16.48%7.72B-9.11%7.79B17.90%8.08B-2.96%8.21B36.42%9.24B
Non Current assets
Long-term equity investment -81.21%6.03M-64.00%12.99M-51.79%21.52M-62.24%26.44M-57.43%32.12M-55.84%36.09M-48.26%44.64M-27.39%70.02M-28.85%75.44M-16.69%81.72M
Fixed assets ----0.71%2.08B-------------7.88%2.07B-----6.36%2.06B----55.78%2.24B
Constru in process ----190.20%705.12M------------92.60%242.98M----62.75%216.39M-----75.62%126.15M
Productive biological assets -45.45%856.33K----54.95%367.15K49.03%965.1K16.26%1.57M-45.48%349K-60.08%236.94K-58.70%647.59K-46.79%1.35M0.79%640.15K
Intangible assets -0.41%315.93M-0.95%318.96M4.37%321.83M3.13%319.72M1.10%317.23M1.81%322.01M49.90%308.35M51.57%310M51.95%313.79M64.05%316.28M
Development expenditure 7.23%27.64M9.68%27.44M10.87%26.92M8.71%26.27M7.59%25.77M7.70%25.02M5.55%24.28M7.27%24.16M7.97%23.95M6.01%23.23M
Goodwill --------0.00%1.1M0.00%1.1M0.00%1.1M0.00%1.1M0.00%1.1M0.00%1.1M0.00%1.1M0.00%1.1M
Long deferred expense 22.97%30M25.67%32.7M120.78%34.6M81.85%33.33M1.57%24.4M2.80%26.02M-49.01%15.67M-44.27%18.33M-34.20%24.02M-3.96%25.31M
Deferred tax assets -11.51%207.86M6.74%242.47M0.87%228.28M3.97%241.72M8.07%234.89M4.59%227.16M8.90%226.31M15.52%232.49M17.01%217.34M6.72%217.19M
Usufruct assets -3.96%9.26M-3.76%9.41M-5.29%9.39M-5.36%9.52M24,011.61%9.64M17,669.52%9.77M14,059.76%9.91M11,729.92%10.06M--40K--55K
Other non current assets -10.40%3.41B-16.49%3.19B-31.53%3B-8.50%3.4B12.87%3.8B63.00%3.82B69.90%4.38B107.83%3.72B942.30%3.37B802.33%2.34B
Total non current assets -1.33%6.84B-2.31%6.62B-12.07%6.41B1.70%6.78B8.59%6.93B26.00%6.78B34.38%7.29B42.24%6.67B119.12%6.38B94.76%5.38B
Total assets 3.67%16.1B7.90%15.64B7.87%16.27B9.24%16.11B6.45%15.53B-0.85%14.49B7.75%15.08B27.79%14.74B28.30%14.59B53.32%14.62B
Liabilities
Current liabilities
Short term loan 0.00%600M12.50%900M0.00%800M-12.50%700.35M0.00%600M-27.27%800M0.00%800M-0.04%800.38M-45.45%600M266.67%1.1B
Notes payable and accounts payable -0.54%204.66M0.48%210.36M14.78%244.12M12.41%197.26M-48.37%205.77M-10.02%209.35M-36.81%212.68M-27.19%175.49M107.16%398.56M23.02%232.65M
-Notes payable 120.68%6.91M-35.10%12.01M97.21%19.86M-----98.58%3.13M101.66%18.51M-81.50%10.07M-36.61%15.31M563.71%220.18M-84.28%9.18M
-Accounts payable -2.41%197.75M3.94%198.34M10.68%224.26M23.15%197.26M13.60%202.64M-14.60%190.83M-28.19%202.61M-26.14%160.17M12.04%178.38M70.94%223.47M
Contract liabilities -11.83%9.79M101.94%19.2M-10.36%10.14M-42.01%8.57M39.26%11.11M-13.09%9.51M139.87%11.31M78.65%14.78M87.23%7.98M82.01%10.94M
Advance receipts ----------------------------------12.6K----
Salaries payable -57.48%514.7K-71.54%136.39K20.45%492.93K39.18%27.89K180.63%1.21M405.13%479.22K25.89%409.25K-99.52%20.04K-90.63%431.38K-97.80%94.87K
Taxs payable -50.37%72.19M-11.99%35.67M-49.30%24.53M145.07%87.75M48.52%145.47M-73.50%40.52M-26.43%48.38M-55.46%35.81M-31.63%97.94M126.50%152.92M
Other payable (including interest and dividends) -0.08%1.25B21.13%1.02B5.72%1.08B14.80%1.29B4.88%1.25B-31.00%840.11M9.86%1.02B4.77%1.12B11.40%1.2B45.50%1.22B
-Dividend payable --93.32M--93.32M------------------------------6.75M
-Other payable ----10.02%924.3M-------------30.62%840.11M----5.17%1.12B----44.70%1.21B
Non current liabilities due within one year 24,357.32%150.76M62,880.98%150.76M127,194.94%300M68,345.11%300.36M-95.89%616.43K-98.40%239.38K-97.64%235.67K-95.69%438.83K--15M--15M
Other current liabilities -11.84%293.7K102.01%575.87K-10.37%304K-41.97%257.11K39.81%333.16K-12.18%285.07K139.90%339.16K78.83%443.03K86.55%238.3K81.92%324.6K
Total current liabilities 3.28%2.29B22.83%2.33B17.40%2.46B20.16%2.58B-4.21%2.22B-30.37%1.9B-2.44%2.1B-3.01%2.15B-8.03%2.32B94.42%2.73B
Current liabilities
Long term loan ----------------66.67%300M66.67%300M57.89%300M57.89%300M--180M--180M
Deferred tax liabilities 32.52%44.74M35.73%40.82M85.82%41.36M105.15%42.82M129.72%33.76M123.76%30.07M15.58%22.26M101.28%20.87M150.32%14.7M-30.11%13.44M
Long term deferred income -11.58%46.46M-7.08%48.09M-6.46%49.63M-5.87%51.18M-7.40%52.54M-6.69%51.75M-8.11%53.06M-6.11%54.37M8.38%56.74M5.94%55.46M
Lease liabilities -4.25%8.67M-11.76%8.57M-3.96%9.23M-1.60%9.15M--9.06M--9.71M--9.61M--9.3M--------
Total non current liabilities -74.74%99.87M-75.11%97.47M-73.96%100.22M-73.18%103.15M57.24%395.36M57.30%391.53M44.17%384.93M48.89%384.54M331.83%251.44M247.70%248.9M
Total liabilities -8.53%2.39B6.10%2.43B3.22%2.56B5.99%2.68B1.81%2.61B-23.05%2.29B2.71%2.48B2.41%2.53B-0.35%2.57B101.86%2.98B
Shareholders equity
Paid-in capital 0.24%1.83B0.24%1.83B0.24%1.83B0.24%1.83B0.00%1.82B0.00%1.82B0.00%1.82B0.00%1.82B0.00%1.82B0.00%1.82B
Capital reserve funds 1.19%1.45B4.08%1.48B5.34%1.5B4.97%1.49B1.40%1.43B1.05%1.42B0.70%1.42B1,239.92%1.42B1,246.75%1.41B1,258.62%1.41B
Surplus reserve funds 9.31%806.81M9.31%806.81M9.31%806.81M9.31%806.81M8.82%738.08M8.82%738.08M8.82%738.08M8.82%738.08M19.35%678.23M19.35%678.23M
Retained profit 10.38%7.66B12.15%7.18B11.45%7.55B13.48%7.29B10.08%6.94B6.89%6.4B12.82%6.77B11.29%6.42B11.85%6.31B18.85%5.99B
Less:Treasury stock --46.75M--46.75M--48.07M--48.07M------------------------
Shareholders equity without minority interests 6.99%11.7B8.30%11.25B8.15%11.63B9.24%11.36B7.00%10.93B4.92%10.39B8.49%10.76B24.73%10.4B26.24%10.22B32.12%9.9B
Minority interests 1.46%2.01B7.87%1.96B12.53%2.08B13.78%2.06B9.94%1.99B4.32%1.81B10.70%1.85B149.22%1.81B157.02%1.81B207.93%1.74B
Total shareholder equity 6.14%13.71B8.24%13.21B8.79%13.71B9.92%13.42B7.44%12.92B4.83%12.2B8.81%12.6B34.71%12.21B36.68%12.02B44.43%11.64B
Total liabilityies and equity 3.67%16.1B7.90%15.64B7.87%16.27B9.24%16.11B6.45%15.53B-0.85%14.49B7.75%15.08B27.79%14.74B28.30%14.59B53.32%14.62B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Superfungus
Superfungus
Intraday+1.17%
Bird Flu
Bird Flu
Intraday+0.81%
Virus Prevention
Virus Prevention
Intraday+0.60%